Ubi Biologics · Research workspace

Biologics R&D, connected.
Data, design, analysis, and pharmacology.

Analyze sequences, design molecules, and simulate PK/PD and QSP models.

42 tools · 83 models

Create account Sign in

Design & analyze

Tools

Analyze sequences and experimental data, predict structures and properties, and design proteins and antibodies.

Explore mechanisms

Modeling

Explore QSP and PK/PD models, compare dosing scenarios, and examine how parameters shape the response.

Open Modeling →

Explore the evidence

Antibody explorer

Follow targets, therapies, and indications from the clinical landscape to the evidence behind each program.

Open Antibody explorer →

New in Ubi

Latest models and tools

Browse all models →Browse all tools →

Models

Atezolizumab PK: standard and loading schedulesCompare serum atezolizumab exposure across the released dosing schedules, with fixed patient covariates and time-varying clearance.CD3×5T4 In Vitro Activation and Cytotoxicity QSPFixed-effect in vitro model linking CD3×5T4 immune-synapse formation to T-cell activation, differentiation, and delayed tumor-cell killing.Crenezumab PK and plasma Aβ turnoverExplore crenezumab exposure and plasma amyloid-beta turnover after the specified intravenous administrations. This reduced two-compartment model tracks drug and target amounts separately.Ustekinumab exposure and baseline covariatesSubcutaneous ustekinumab absorption, systemic distribution and elimination under the reported reference priors, with explicit exposure and amount accounting.

Tools

HLAIIPredHLA-II peptide presentation prediction ImmunoGeNNProtein-level DRB1 population-risk screening MHCFlurryMulti-allele MHC-I presentation prediction RFantibodyAntibody structure design against a supplied antigen

Ubi Biologics